Mean % of 5-Year outcomes | % Delta (Pred-Obs) | ||||
---|---|---|---|---|---|
Number | % | AOL predicted | YTR observed (95% CI) | ||
All patients | 765 | 100 | 78.19 | 79.35 (76.3, 82.05) | −1.16 |
Age | |||||
< 50 | 177 | 23.1 | 83.37 | 87.57 (81.74, 91.63) | −4.2 |
50-59 | 226 | 29.5 | 79.56 | 80.09 (74.26, 84.73) | −0.53 |
60-69 | 270 | 35.3 | 76.51 | 76.3 (70.76, 80.93) | 0.21 |
≥ 70 | 92 | 12.1 | 69.75 | 70.65 (60.2, 78.84) | −0.9 |
Sex | |||||
Male | 450 | 58.8 | 77.57 | 78.67 (74.59, 82.17) | −1.1 |
Female | 315 | 41.2 | 79.06 | 80.32 (75.48, 84.3) | −1.26 |
T stage | |||||
T1 | 4 | 0.5 | 89.50 | 75 (12.79, 96.05) | 14.5 |
T2 | 20 | 2.6 | 82.35 | 85 (60.38, 94.9) | −2.65 |
T3 | 712 | 93.1 | 78.78 | 80.48 (77.37, 83.2) | −1.7 |
T4 | 29 | 3.8 | 59.21 | 48.28 (29.47, 64.78) | 10.93 |
Number of positive node | |||||
0 | 420 | 54.9 | 86.87 | 86.43 (82.77, 89.36) | 0.44 |
1-3 | 242 | 31.6 | 74.31 | 77.27 (71.46, 82.05) | −2.96 |
4-10 | 79 | 10.3 | 57.24* | 69.62 (58.19, 78.49) | −12.38 |
> 10 | 24 | 3.2 | 34.25* | 8.33 (1.44, 23.3) | 25.92 |
Number of examined nodes | |||||
1-3 | 3 | 0.4 | 79.33* | 100 (100, 100) | −20.67 |
4-10 | 83 | 10.9 | 76.77 | 77.11 (66.49, 84.74) | −0.34 |
> 10 | 679 | 88.7 | 78.35 | 79.53 (76.29, 82.37) | −1.18 |
Histologic grade | |||||
1 | 94 | 12.3 | 82.44 | 81.91 (72.53, 88.35) | 0.53 |
2 | 561 | 73.3 | 78.52 | 79.14 (75.54, 82.28) | −0.62 |
3 | 44 | 5.8 | 69.50 | 72.73 (57, 83.49) | −3.23 |
Undefined | 66 | 8.6 | 75.09 | 81.82 (70.21, 89.24) | −6.73 |